These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 16822964)
1. Paraoxonase cluster polymorphisms are associated with sporadic ALS. Saeed M; Siddique N; Hung WY; Usacheva E; Liu E; Sufit RL; Heller SL; Haines JL; Pericak-Vance M; Siddique T Neurology; 2006 Sep; 67(5):771-6. PubMed ID: 16822964 [TBL] [Abstract][Full Text] [Related]
2. Association analysis of PON polymorphisms in sporadic ALS in a Chinese population. Chen Y; Huang R; Chen K; Song W; Yang Y; Zhao B; Li J; Shang HF Neurobiol Aging; 2012 Dec; 33(12):2949.e1-3. PubMed ID: 22884547 [TBL] [Abstract][Full Text] [Related]
5. A common haplotype within the PON1 promoter region is associated with sporadic ALS. Landers JE; Shi L; Cho TJ; Glass JD; Shaw CE; Leigh PN; Diekstra F; Polak M; Rodriguez-Leyva I; Niemann S; Traynor BJ; McKenna-Yasek D; Sapp PC; Al-Chalabi A; Wills AM; Brown RH Amyotroph Lateral Scler; 2008 Oct; 9(5):306-14. PubMed ID: 18618303 [TBL] [Abstract][Full Text] [Related]
6. Association analysis of PON2 genetic variants with serum paraoxonase activity and systemic lupus erythematosus. Dasgupta S; Demirci FY; Dressen AS; Kao AH; Rhew EY; Ramsey-Goldman R; Manzi S; Kammerer CM; Kamboh MI BMC Med Genet; 2011 Jan; 12():7. PubMed ID: 21223581 [TBL] [Abstract][Full Text] [Related]
7. Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden. Valdmanis PN; Kabashi E; Dyck A; Hince P; Lee J; Dion P; D'Amour M; Souchon F; Bouchard JP; Salachas F; Meininger V; Andersen PM; Camu W; Dupré N; Rouleau GA Neurology; 2008 Aug; 71(7):514-20. PubMed ID: 18695162 [TBL] [Abstract][Full Text] [Related]
8. A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Wills AM; Cronin S; Slowik A; Kasperaviciute D; Van Es MA; Morahan JM; Valdmanis PN; Meininger V; Melki J; Shaw CE; Rouleau GA; Fisher EM; Shaw PJ; Morrison KE; Pamphlett R; Van den Berg LH; Figlewicz DA; Andersen PM; Al-Chalabi A; Hardiman O; Purcell S; Landers JE; Brown RH Neurology; 2009 Jul; 73(1):16-24. PubMed ID: 19321847 [TBL] [Abstract][Full Text] [Related]
9. The -A162G polymorphism of the PON1 gene and the risk of sporadic amyotrophic lateral sclerosis. Zawiślak D; Ostrowska M; Golenia A; Marona M; Tomik B; Wołkow P; Gryz-Kurek E; Szczudlik A; Słowik A Neurol Neurochir Pol; 2010; 44(3):246-50. PubMed ID: 20625960 [TBL] [Abstract][Full Text] [Related]
10. A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis. Morahan JM; Yu B; Trent RJ; Pamphlett R Neurotoxicology; 2007 May; 28(3):532-40. PubMed ID: 17204329 [TBL] [Abstract][Full Text] [Related]
11. Rare and common paraoxonase gene variants in amyotrophic lateral sclerosis patients. van Blitterswijk M; Blokhuis A; van Es MA; van Vught PW; Rowicka PA; Schelhaas HJ; van der Kooi AJ; de Visser M; Veldink JH; van den Berg LH Neurobiol Aging; 2012 Aug; 33(8):1845.e1-3. PubMed ID: 22330174 [TBL] [Abstract][Full Text] [Related]
12. Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS. Wills AM; Landers JE; Zhang H; Richter RJ; Caraganis AJ; Cudkowicz ME; Furlong CE; Brown RH Neurology; 2008 Mar; 70(12):929-34. PubMed ID: 18347314 [TBL] [Abstract][Full Text] [Related]
13. Effects of PON polymorphisms and haplotypes on molecular phenotype in Mexican-American mothers and children. Huen K; Barcellos L; Beckman K; Rose S; Eskenazi B; Holland N Environ Mol Mutagen; 2011 Mar; 52(2):105-16. PubMed ID: 20839225 [TBL] [Abstract][Full Text] [Related]
14. Lack of association of PON polymorphisms with sporadic ALS in an Italian population. Ricci C; Battistini S; Cozzi L; Benigni M; Origone P; Verriello L; Lunetta C; Cereda C; Milani P; Greco G; Patrosso MC; Causarano R; Caponnetto C; Giannini F; Corbo M; Penco S Neurobiol Aging; 2011 Mar; 32(3):552.e7-13. PubMed ID: 20381198 [TBL] [Abstract][Full Text] [Related]
15. Interaction between PON1 and population density in amyotrophic lateral sclerosis. Diekstra FP; Beleza-Meireles A; Leigh NP; Shaw CE; Al-Chalabi A Neuroreport; 2009 Jan; 20(2):186-90. PubMed ID: 19104460 [TBL] [Abstract][Full Text] [Related]
16. PON1 is a disease modifier gene in amyotrophic lateral sclerosis: association of the Q192R polymorphism with bulbar onset and reduced survival. Verde F; Tiloca C; Morelli C; Doretti A; Poletti B; Maderna L; Messina S; Gentilini D; Fogh I; Ratti A; Silani V; Ticozzi N Neurol Sci; 2019 Jul; 40(7):1469-1473. PubMed ID: 30903418 [TBL] [Abstract][Full Text] [Related]
17. Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ticozzi N; LeClerc AL; Keagle PJ; Glass JD; Wills AM; van Blitterswijk M; Bosco DA; Rodriguez-Leyva I; Gellera C; Ratti A; Taroni F; McKenna-Yasek D; Sapp PC; Silani V; Furlong CE; Brown RH; Landers JE Ann Neurol; 2010 Jul; 68(1):102-7. PubMed ID: 20582942 [TBL] [Abstract][Full Text] [Related]
18. Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis. Lee YH; Kim JH; Seo YH; Choi SJ; Ji JD; Song GG Neurol Sci; 2015 Jan; 36(1):11-20. PubMed ID: 25301263 [TBL] [Abstract][Full Text] [Related]
19. Paraoxonase gene polymorphisms and haplotype analysis in a stroke population. Pasdar A; Ross-Adams H; Cumming A; Cheung J; Whalley L; St Clair D; MacLeod MJ BMC Med Genet; 2006 Mar; 7():28. PubMed ID: 16551349 [TBL] [Abstract][Full Text] [Related]
20. Interactions between superoxide dismutase and paraoxonase polymorphic variants in nonsyndromic cleft lip with or without cleft palate in the Brazilian population. Machado RA; de Oliveira Silva C; Persuhn DC; de Melo Cavalcanti Dantas V; de Almeida Reis SR; Wu T; Line SR; Martelli-Junior H; Graner E; Coletta RD Environ Mol Mutagen; 2019 Mar; 60(2):185-196. PubMed ID: 30240501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]